Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciara L Freeman

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2023
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with MyelomaCiara L Freeman, Reginald Atkins, Indumathy Varadarajan, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Leukemia|February 24, 2025
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702Rahul Banerjee, Amber R Fritz, Othman S Akhtar, et al.
Blood|October 23, 2024
CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCLWaleed Alduaij, Aixiang Jiang, Diego Villa, et al.
Blood|September 2, 2020
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOPCiara L Freeman, Kerry J Savage, Diego R Villa, et al.
Blood Advances|October 10, 2025
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL MorphologyWaleed Alduaij, Laurie H Sehn, Jean-Nicolas Champagne, et al.
Blood Advances|August 26, 2021
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approachPhoebe T M Cheng, Diego Villa, R Petter Tonseth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 20, 2025
Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myelomaCiara L Freeman, Julieta Abraham-Miranda, Meghan Menges, et al.
Transplantation and Cellular Therapy|December 20, 2023
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T TherapyOthman S Akhtar, Karnav Modi, Jongphil Kim, et al.
Blood|October 27, 2022
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma populationWaleed Alduaij, Brett Collinge, Susana Ben-Neriah, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2023
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with MyelomaCiara L Freeman, Reginald Atkins, Indumathy Varadarajan, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Leukemia|February 24, 2025
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702Rahul Banerjee, Amber R Fritz, Othman S Akhtar, et al.
Blood|October 23, 2024
CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCLWaleed Alduaij, Aixiang Jiang, Diego Villa, et al.
Blood|September 2, 2020
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOPCiara L Freeman, Kerry J Savage, Diego R Villa, et al.
Blood Advances|October 10, 2025
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL MorphologyWaleed Alduaij, Laurie H Sehn, Jean-Nicolas Champagne, et al.
Blood Advances|August 26, 2021
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approachPhoebe T M Cheng, Diego Villa, R Petter Tonseth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 20, 2025
Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myelomaCiara L Freeman, Julieta Abraham-Miranda, Meghan Menges, et al.
Transplantation and Cellular Therapy|December 20, 2023
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T TherapyOthman S Akhtar, Karnav Modi, Jongphil Kim, et al.
Blood|October 27, 2022
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma populationWaleed Alduaij, Brett Collinge, Susana Ben-Neriah, et al.
Pageof 7